Phase I/II study of escalating doses of concomitant zactima (ZD6474) and thoracic radiotherapy followed by daily fixed doses of zactima in locally-advanced NSCLC [non-small cell lung cancer].
Phase of Trial: Phase I/II
Latest Information Update: 06 Nov 2006
At a glance
- Drugs Vandetanib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Nov 2006 New trial record.